Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...

At only age 28, the newlywed and busy teacher initially dismissed her symptoms. As her cough and fatigue worsened, she ...

The safety profile for Imfinzi was generally manageable and consistent with the known profile of this medicine.

Cancer is a complex condition marked by the uncontrolled growth of cells in the body. When this process begins in the lungs, ...

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...

Approval based on ADRIATIC Phase III trial results which showed a 27% reduction in the risk of death versus placebo ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

Cancer patients who sought a virtual second opinion received a recommendation for a treatment change more than half the time, researchers found.

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.

Discover the four vital indicators that your cancer treatment is effective, from tumor shrinkage to symptom relief, helping ...

A 31-year-old female doctor with cancer chose not to undergo surgery and instead sought healing through a macrobiotic diet.

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...